Response of the Primary Tumor to Neoadjuvant Sunitinib in Patients With Advanced Renal Cell Carcinoma
Author:
Affiliation:
1. Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, Ohio
2. Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference16 articles.
1. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial;Mickisch;Lancet,2001
2. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer;Flanigan;N Engl J Med,2001
3. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis;Flanigan;J Urol,2004
4. The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy;Rini;J Urol,2007
5. Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions;Rini;Clin Cancer Res,2007
Cited by 171 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Complete response of metastatic RCC with caval vein thrombus following treatment with pembrolizumab and axitinib: is it possible to extend the indications for systemic therapy?;Minerva Urology and Nephrology;2024-06
2. Perioperative systemic treatments in renal cell carcinoma;Frontiers in Oncology;2024-05-21
3. Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update;Journal of Cancer Research and Clinical Oncology;2024-04-09
4. Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review;World Journal of Urology;2024-01-20
5. Genitourinary cancer neoadjuvant therapies: current and future approaches;Trends in Cancer;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3